Skip to main content
Premium Trial:

Request an Annual Quote

Roche Diagnostics Says Judge Ruled in Its Favor in Enzo Diagnostic Case

This article has been updated to include the total number of patents under dispute. Enzo claims that several firms infringe eight of its patents.

 

NEW YORK, July 21 (GenomeWeb News) - Roche Diagnostics today said that a New York district judge ruled in its favor on key aspects of Enzo Biochem's patent-infringement case against the company.

 

According to Roche, the judge adopted "virtually all" of the interpretations proposed by Roche and its co-parties relating to seven Enzo patents.

 

Enzo earlier this week claimed the judge supported its patent-infringement claims against Affymetrix, Roche, Amersham, PerkinElmer, Sigma Aldrich, Orchid Biosciences, and Molecular Probes for eight of its patents.

 

The litigation, first filed in 2002, concerns products and techniques for detecting genetic information in biological samples, such as blood. Enzo claimed Roche's AmpliChip CYP450 Test infringed its patent covering the "soluble signal" and the testing format.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.